메뉴 건너뛰기




Volumn 74, Issue 4, 2014, Pages 1272-1283

High fidelity patient-derived xenografts for accelerating prostate cancer discovery and drug development

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; DRUG DISCOVERY; EARLY DETECTION OF CANCER; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED NOD; MICE, SCID; MICE, TRANSGENIC; NEOPLASM TRANSPLANTATION; PROSTATIC NEOPLASMS; TISSUE AND ORGAN PROCUREMENT; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84894275509     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-13-2921-T     Document Type: Article
Times cited : (288)

References (57)
  • 2
    • 70749101076 scopus 로고    scopus 로고
    • Steroid hormone receptors in prostate cancer: A hard habit to break?
    • Attard G, Cooper CS, de Bono JS. Steroid hormone receptors in prostate cancer: a hard habit to break? Cancer Cell 2009;16:458-62.
    • (2009) Cancer Cell , vol.16 , pp. 458-462
    • Attard, G.1    Cooper, C.S.2    De Bono, J.S.3
  • 3
    • 80053078529 scopus 로고    scopus 로고
    • Common gene rearrangements in prostate cancer
    • Rubin MA, Maher CA, Chinnaiyan AM. Common gene rearrangements in prostate cancer. J Clin Oncol 2011;29:3659-68.
    • (2011) J Clin Oncol , vol.29 , pp. 3659-3668
    • Rubin, M.A.1    Maher, C.A.2    Chinnaiyan, A.M.3
  • 7
    • 84975685847 scopus 로고    scopus 로고
    • From sequence to molecular pathology, and a mechanism driving the neuroendocrine phenotype in prostate cancer
    • Lapuk AV, Wu C, Wyatt AW, McPherson A, McConeghy BJ, Brahmb-hatt S, et al. From sequence to molecular pathology, and a mechanism driving the neuroendocrine phenotype in prostate cancer. J Pathol 2012;227:286-97.
    • (2012) J Pathol , vol.227 , pp. 286-297
    • Lapuk, A.V.1    Wu, C.2    Wyatt, A.W.3    McPherson, A.4    McConeghy, B.J.5    Brahmb-Hatt, S.6
  • 8
    • 2042458747 scopus 로고    scopus 로고
    • Relationships between drug activity in NCI preclin-ical in vitro and in vivo models and early clinical trials
    • Johnson JI, Decker S, Zaharevitz D, Rubinstein LV, Venditti JM, Schepartz S, et al. Relationships between drug activity in NCI preclin-ical in vitro and in vivo models and early clinical trials. Br J Cancer 2001;84:1424-31.
    • (2001) Br J Cancer , vol.84 , pp. 1424-1431
    • Johnson, J.I.1    Decker, S.2    Zaharevitz, D.3    Rubinstein, L.V.4    Venditti, J.M.5    Schepartz, S.6
  • 9
    • 33748331308 scopus 로고    scopus 로고
    • The mighty mouse: Genetically engineered mouse models in cancer drug development
    • Sharpless NE, Depinho RA. The mighty mouse: genetically engineered mouse models in cancer drug development. Nat Rev Drug Discov 2006;5:741-54.
    • (2006) Nat Rev Drug Discov , vol.5 , pp. 741-754
    • Sharpless, N.E.1    Depinho, R.A.2
  • 10
    • 33846995628 scopus 로고    scopus 로고
    • Economics of new oncology drug development
    • DiMasi JA, Grabowski HG. Economics of new oncology drug development. J Clin Oncol 2007;25:209-16.
    • (2007) J Clin Oncol , vol.25 , pp. 209-216
    • Dimasi, J.A.1    Grabowski, H.G.2
  • 11
    • 58749103524 scopus 로고    scopus 로고
    • From human to mouse and back: 'Tumorgraft' models surge in popularity
    • Garber K. From human to mouse and back: 'tumorgraft' models surge in popularity. J Natl Cancer Inst 2009;101:6-8.
    • (2009) J Natl Cancer Inst , vol.101 , pp. 6-8
    • Garber, K.1
  • 13
    • 16944366096 scopus 로고    scopus 로고
    • Progression of metastatic human prostate cancer to androgen independence in immunodeficient SCID mice
    • Klein KA, Reiter RE, Redula J, Moradi H, Zhu XL, Brothman AR, et al. Progression of metastatic human prostate cancer to androgen independence in immunodeficient SCID mice. Nat Med 1997;3:402-8.
    • (1997) Nat Med , vol.3 , pp. 402-408
    • Klein, K.A.1    Reiter, R.E.2    Redula, J.3    Moradi, H.4    Zhu, X.L.5    Brothman, A.R.6
  • 16
    • 58549118535 scopus 로고    scopus 로고
    • Direct in vivo xenograft tumor model for predicting chemotherapeutic drug response in cancer patients
    • Rubio-Viqueira B, Hidalgo M. Direct in vivo xenograft tumor model for predicting chemotherapeutic drug response in cancer patients. Clin Pharmacol Ther 2009;85:217-21.
    • (2009) Clin Pharmacol Ther , vol.85 , pp. 217-221
    • Rubio-Viqueira, B.1    Hidalgo, M.2
  • 17
    • 0037441315 scopus 로고    scopus 로고
    • Quantitation of apoptotic activity following castration in human pros-tatic tissue in vivo
    • Staack A, Kassis AP, Olshen A, Wang Y, Wu D, Carroll PR, et al. Quantitation of apoptotic activity following castration in human pros-tatic tissue in vivo. Prostate 2003;54:212-9.
    • (2003) Prostate , vol.54 , pp. 212-219
    • Staack, A.1    Kassis, A.P.2    Olshen, A.3    Wang, Y.4    Wu, D.5    Carroll, P.R.6
  • 18
    • 20344361938 scopus 로고    scopus 로고
    • Development and characterization of efficient xenograft models for benign and malignant human prostate tissue
    • Wang Y, Revelo MP, Sudilovsky D, Cao M, Chen WG, Goetz L, et al. Development and characterization of efficient xenograft models for benign and malignant human prostate tissue. Prostate 2005;64: 149-59.
    • (2005) Prostate , vol.64 , pp. 149-159
    • Wang, Y.1    Revelo, M.P.2    Sudilovsky, D.3    Cao, M.4    Chen, W.G.5    Goetz, L.6
  • 20
    • 84880560009 scopus 로고    scopus 로고
    • A preclinical xenograft model identifies castration-tolerant can-cer-repopulating cells in localized prostate tumors
    • Toivanen R, Frydenberg M, Murphy D, Pedersen J, Ryan A, Pook D, et al. A preclinical xenograft model identifies castration-tolerant can-cer-repopulating cells in localized prostate tumors. Sci Transl Med 2013;5:187ra71.
    • (2013) Sci Transl Med , vol.5
    • Toivanen, R.1    Frydenberg, M.2    Murphy, D.3    Pedersen, J.4    Ryan, A.5    Pook, D.6
  • 21
    • 49249106186 scopus 로고    scopus 로고
    • ASAP1, a gene at 8q24, is associated with prostate cancer metastasis
    • Lin D, Watahiki A, Bayani J, Zhang F, Liu L, Ling V, et al. ASAP1, a gene at 8q24, is associated with prostate cancer metastasis. Cancer Res 2008;68:4352-9.
    • (2008) Cancer Res , vol.68 , pp. 4352-4359
    • Lin, D.1    Watahiki, A.2    Bayani, J.3    Zhang, F.4    Liu, L.5    Ling, V.6
  • 22
    • 84975810758 scopus 로고    scopus 로고
    • Integrated genome and transcriptome sequencing identifies a novel form of hybrid and aggressive prostate cancer
    • Wu C, Wyatt AW, Lapuk AV, McPherson A, McConeghy BJ, Bell RH, et al. Integrated genome and transcriptome sequencing identifies a novel form of hybrid and aggressive prostate cancer. J Pathol 2012; 227:53-61.
    • (2012) J Pathol , vol.227 , pp. 53-61
    • Wu, C.1    Wyatt, A.W.2    Lapuk, A.V.3    McPherson, A.4    McConeghy, B.J.5    Bell, R.H.6
  • 23
    • 61449172037 scopus 로고    scopus 로고
    • Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
    • Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009;4:44-57.
    • (2009) Nat Protoc , vol.4 , pp. 44-57
    • Huang Da, W.1    Sherman, B.T.2    Lempicki, R.A.3
  • 24
    • 84860168795 scopus 로고    scopus 로고
    • Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets
    • Beltran H, Rickman DS, Park K, Chae SS, Sboner A, MacDonald TY, et al. Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets. Cancer Discov 2011;1: 487-95.
    • (2011) Cancer Discov , vol.1 , pp. 487-495
    • Beltran, H.1    Rickman, D.S.2    Park, K.3    Chae, S.S.4    Sboner, A.5    Macdonald, T.Y.6
  • 25
    • 84868332770 scopus 로고    scopus 로고
    • NFuse: Discovery of complex genomic rearrangements in cancer using high-throughput sequencing
    • McPherson A, Wu C, Wyatt AW, Shah S, Collins C, Sahinalp SC.nFuse: discovery of complex genomic rearrangements in cancer using high-throughput sequencing. Genome Res 2012;22:2250-61.
    • (2012) Genome Res , vol.22 , pp. 2250-2261
    • McPherson, A.1    Wu, C.2    Wyatt, A.W.3    Shah, S.4    Collins, C.5    Sahinalp, S.C.6
  • 26
    • 0026053945 scopus 로고
    • Epstein-Barr virus (EBV)-associated lymphoproliferative disease in the SCID mouse model: Implications for the pathogenesis of EBV-positive lymphomas in man
    • Rowe M, Young LS, Crocker J, Stokes H, Henderson S, Rickinson AB. Epstein-Barr virus (EBV)-associated lymphoproliferative disease in the SCID mouse model: implications for the pathogenesis of EBV-positive lymphomas in man. J Exp Med 1991;173:147-58.
    • (1991) J Exp Med , vol.173 , pp. 147-158
    • Rowe, M.1    Young, L.S.2    Crocker, J.3    Stokes, H.4    Henderson, S.5    Rickinson, A.B.6
  • 27
    • 33846479832 scopus 로고    scopus 로고
    • Unusual and underappreciated: Small cell carcinoma of the prostate
    • Palmgren JS, Karavadia SS, Wakefield MR. Unusual and underappreciated: small cell carcinoma of the prostate. Semin Oncol 2007;34: 22-9.
    • (2007) Semin Oncol , vol.34 , pp. 22-29
    • Palmgren, J.S.1    Karavadia, S.S.2    Wakefield, M.R.3
  • 29
  • 31
    • 84856530618 scopus 로고    scopus 로고
    • Common structural and epigenetic changes in the genome of castration-resistant prostate cancer
    • Friedlander TW, Roy R, Tomlins SA, Ngo VT, Kobayashi Y, Azameera A, et al. Common structural and epigenetic changes in the genome of castration-resistant prostate cancer. Cancer Res 2012;72:616-25.
    • (2012) Cancer Res , vol.72 , pp. 616-625
    • Friedlander, T.W.1    Roy, R.2    Tomlins, S.A.3    Ngo, V.T.4    Kobayashi, Y.5    Azameera, A.6
  • 32
  • 34
    • 66749188650 scopus 로고    scopus 로고
    • Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate
    • Carver BS, Tran J, Gopalan A, Chen Z, Shaikh S, Carracedo A, et al. Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate. Nat Genet 2009;41:619-24.
    • (2009) Nat Genet , vol.41 , pp. 619-624
    • Carver, B.S.1    Tran, J.2    Gopalan, A.3    Chen, Z.4    Shaikh, S.5    Carracedo, A.6
  • 36
    • 79961031503 scopus 로고    scopus 로고
    • ERG-TMPRSS2 rearrangement is shared by concurrent prostatic adenocarcinoma and prostatic small cell carcinoma and absent in small cell carcinoma of the urinary bladder: Evidence supporting monoclonal origin
    • Williamson SR, Zhang S, Yao JL, Huang J, Lopez-Beltran A, Shen S, et al. ERG-TMPRSS2 rearrangement is shared by concurrent prostatic adenocarcinoma and prostatic small cell carcinoma and absent in small cell carcinoma of the urinary bladder: evidence supporting monoclonal origin. Mod Pathol 2011;24:1120-7.
    • (2011) Mod Pathol , vol.24 , pp. 1120-1127
    • Williamson, S.R.1    Zhang, S.2    Yao, J.L.3    Huang, J.4    Lopez-Beltran, A.5    Shen, S.6
  • 38
    • 77950592442 scopus 로고    scopus 로고
    • Establishment and genomic characterization of mouse xenografts of human primary prostate tumors
    • Priolo C, Agostini M, Vena N, Ligon AH, Fiorentino M, Shin E, et al. Establishment and genomic characterization of mouse xenografts of human primary prostate tumors. Am J Pathol 2010;176:1901-13.
    • (2010) Am J Pathol , vol.176 , pp. 1901-1913
    • Priolo, C.1    Agostini, M.2    Vena, N.3    Ligon, A.H.4    Fiorentino, M.5    Shin, E.6
  • 39
    • 77954582489 scopus 로고    scopus 로고
    • Tissue slice grafts: An in vivo model of human prostate androgen signaling
    • Zhao H, Nolley R, Chen Z, Peehl DM. Tissue slice grafts: an in vivo model of human prostate androgen signaling. Am J Pathol 2010; 177:229-39.
    • (2010) Am J Pathol , vol.177 , pp. 229-239
    • Zhao, H.1    Nolley, R.2    Chen, Z.3    Peehl, D.M.4
  • 40
    • 0017158894 scopus 로고
    • Tissue pressures and fluid dynamics in the kidney
    • Ott CE, Knox FG. Tissue pressures and fluid dynamics in the kidney. Fed Proc 1976;35:1872-5.
    • (1976) Fed Proc , vol.35 , pp. 1872-1875
    • Ott, C.E.1    Knox, F.G.2
  • 41
    • 8944223083 scopus 로고
    • Renal lymph: Vital for the kidney and valuable for the physiologist
    • Pinter G. Renal lymph: vital for the kidney and valuable for the physiologist. Physiology 1988;3:189-93.
    • (1988) Physiology , vol.3 , pp. 189-193
    • Pinter, G.1
  • 42
    • 0032708879 scopus 로고    scopus 로고
    • Early events in the formation of a tissue structure from dispersed bovine adrenocortical cells following transplantation into scid mice
    • Tunstead JR, Thomas M, Hornsby PJ. Early events in the formation of a tissue structure from dispersed bovine adrenocortical cells following transplantation into scid mice. J Mol Med 1999;77:666-76.
    • (1999) J Mol Med , vol.77 , pp. 666-676
    • Tunstead, J.R.1    Thomas, M.2    Hornsby, P.J.3
  • 43
    • 0017146252 scopus 로고
    • Epithelial-stromal interactions in development of the uro-genital tract
    • Cunha GR. Epithelial-stromal interactions in development of the uro-genital tract. Int Rev Cytol 1976;47:137-94.
    • (1976) Int Rev Cytol , vol.47 , pp. 137-194
    • Cunha, G.R.1
  • 44
    • 0021021278 scopus 로고
    • Initial clinical trials of the subrenal capsule assay as a predictor of tumor response to chemotherapy
    • Griffin TW, Bogden AE, Reich SD, Antonelli D, Hunter RE, Ward A, et al. Initial clinical trials of the subrenal capsule assay as a predictor of tumor response to chemotherapy. Cancer 1983;52:2185-92.
    • (1983) Cancer , vol.52 , pp. 2185-2192
    • Griffin, T.W.1    Bogden, A.E.2    Reich, S.D.3    Antonelli, D.4    Hunter, R.E.5    Ward, A.6
  • 45
    • 0033561535 scopus 로고    scopus 로고
    • Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone
    • Nemeth JA, Harb JF, Barroso U Jr, He Z, Grignon DJ, Cher ML. Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone. Cancer Res 1999;59:1987-93.
    • (1999) Cancer Res , vol.59 , pp. 1987-1993
    • Nemeth, J.A.1    Harb, J.F.2    Barroso Jr., U.3    He, Z.4    Grignon, D.J.5    Cher, M.L.6
  • 46
    • 0035266413 scopus 로고    scopus 로고
    • Establishment of a novel species-and tissue-specific metastasis model of human prostate cancer in humanized non-obese diabetic/severe combined immunodeficient mice engrafted with human adult lung and bone
    • Yonou H, Yokose T, Kamijo T, Kanomata N, Hasebe T, Nagai K, et al. Establishment of a novel species-and tissue-specific metastasis model of human prostate cancer in humanized non-obese diabetic/severe combined immunodeficient mice engrafted with human adult lung and bone. Cancer Res 2001;61:2177-82.
    • (2001) Cancer Res , vol.61 , pp. 2177-2182
    • Yonou, H.1    Yokose, T.2    Kamijo, T.3    Kanomata, N.4    Hasebe, T.5    Nagai, K.6
  • 47
    • 67349257845 scopus 로고    scopus 로고
    • Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer
    • Liu W, Laitinen S, Khan S, Vihinen M, Kowalski J, Yu G, et al. Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer. Nat Med 2009;15:559-65.
    • (2009) Nat Med , vol.15 , pp. 559-565
    • Liu, W.1    Laitinen, S.2    Khan, S.3    Vihinen, M.4    Kowalski, J.5    Yu, G.6
  • 49
    • 81255135837 scopus 로고    scopus 로고
    • Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes
    • DeRose YS, Wang G, Lin YC, Bernard PS, Buys SS, Ebbert MT, et al. Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes. Nat Med 2011;17:1514-20.
    • (2011) Nat Med , vol.17 , pp. 1514-1520
    • Derose, Y.S.1    Wang, G.2    Lin, Y.C.3    Bernard, P.S.4    Buys, S.S.5    Ebbert, M.T.6
  • 50
    • 33746068275 scopus 로고    scopus 로고
    • Establishment in severe combined immunodeficiency mice of sub-renal capsule xenografts and transplantable tumor lines from a variety of primary human lung cancers: Potential models for studying tumor progression-related changes
    • Cutz JC, Guan J, Bayani J, Yoshimoto M, Xue H, Sutcliffe M, et al. Establishment in severe combined immunodeficiency mice of sub-renal capsule xenografts and transplantable tumor lines from a variety of primary human lung cancers: potential models for studying tumor progression-related changes. Clin Cancer Res 2006;12: 4043-54.
    • (2006) Clin Cancer Res , vol.12 , pp. 4043-4054
    • Cutz, J.C.1    Guan, J.2    Bayani, J.3    Yoshimoto, M.4    Xue, H.5    Sutcliffe, M.6
  • 51
    • 84863013857 scopus 로고    scopus 로고
    • Modeling a lethal prostate cancer variant with small-cell carcinoma features
    • Tzelepi V, Zhang J, Lu JF, Kleb B, Wu G, Wan X, et al. Modeling a lethal prostate cancer variant with small-cell carcinoma features. Clin Cancer Res 2012;18:666-77.
    • (2012) Clin Cancer Res , vol.18 , pp. 666-677
    • Tzelepi, V.1    Zhang, J.2    Lu, J.F.3    Kleb, B.4    Wu, G.5    Wan, X.6
  • 53
    • 84866948935 scopus 로고    scopus 로고
    • Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: Final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study
    • Fizazi K, Scher HI, Molina A, Logothetis CJ, Chi KN, Jones RJ, et al. Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study. Lancet Oncol 2012;13:983-92.
    • (2012) Lancet Oncol , vol.13 , pp. 983-992
    • Fizazi, K.1    Scher, H.I.2    Molina, A.3    Logothetis, C.J.4    Chi, K.N.5    Jones, R.J.6
  • 54
    • 77649178137 scopus 로고    scopus 로고
    • Patient-derived first generation xenografts of non-small cell lung cancers: Promising tools for predicting drug responses for personalized chemotherapy
    • Dong X, Guan J, English JC, Flint J, Yee J, Evans K, et al. Patient-derived first generation xenografts of non-small cell lung cancers: promising tools for predicting drug responses for personalized chemotherapy. Clin Cancer Res 2010;16:1442-51.
    • (2010) Clin Cancer Res , vol.16 , pp. 1442-1451
    • Dong, X.1    Guan, J.2    English, J.C.3    Flint, J.4    Yee, J.5    Evans, K.6
  • 55
    • 79951819983 scopus 로고    scopus 로고
    • Tumor growth inhibition by olaparib in BRCA2 germline-mutated patient-derived ovarian cancer tissue xenografts
    • Kortmann U, McAlpine JN, Xue H, Guan J, Ha G, Tully S, et al. Tumor growth inhibition by olaparib in BRCA2 germline-mutated patient-derived ovarian cancer tissue xenografts. Clin Cancer Res 2011;17: 783-91.
    • (2011) Clin Cancer Res , vol.17 , pp. 783-791
    • Kortmann, U.1    McAlpine, J.N.2    Xue, H.3    Guan, J.4    Ha, G.5    Tully, S.6
  • 56
    • 84859414102 scopus 로고    scopus 로고
    • Next generation sequencing of prostate cancer from a patient identifies a deficiency of methylthioadenosine phosphorylase, an exploitable tumor target
    • Collins CC, Volik SV, Lapuk AV, Wang Y, Gout PW, Wu C, et al. Next generation sequencing of prostate cancer from a patient identifies a deficiency of methylthioadenosine phosphorylase, an exploitable tumor target. Mol Cancer Ther 2012;11:775-83.
    • (2012) Mol Cancer Ther , vol.11 , pp. 775-783
    • Collins, C.C.1    Volik, S.V.2    Lapuk, A.V.3    Wang, Y.4    Gout, P.W.5    Wu, C.6
  • 57
    • 77953280591 scopus 로고    scopus 로고
    • Regression of castrate-recurrent prostate cancer by a small-molecule inhibitor of the amino-terminus domain of the androgen receptor
    • Andersen RJ, Mawji NR, Wang J, Wang G, Haile S, Myung JK, et al. Regression of castrate-recurrent prostate cancer by a small-molecule inhibitor of the amino-terminus domain of the androgen receptor. Cancer Cell 2010;17:535-46.
    • (2010) Cancer Cell , vol.17 , pp. 535-546
    • Andersen, R.J.1    Mawji, N.R.2    Wang, J.3    Wang, G.4    Haile, S.5    Myung, J.K.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.